Cell death and cell cycle perturbation in the developmental toxicity of the demethylating agent, 5-aza-2'-deoxycytidine

Teratology
J M RogersNeil Chernoff

Abstract

DNA methylation is a probable mechanism for regulating gene expression, and alterations in methylation may significantly affect embryonic development. We administered the cytidine analogue 5-aza-2'-deoxycytidine (dAZA), a specific and potent demethylator of DNA, to pregnant mice to determine its teratogenicity and effects on embryonic cell death and cell cycle. Groups of females were dosed intraperitoneally on gestation day 10 with doses of 0.05-3 mg/kg dAZA and killed at 4, 8, or 28 hr later. Two embryos per litter were immediately stained with Nile blue sulfate (NBS) to identify areas of cell death; the remaining embryos were frozen and stored for subsequent flow cytometric (FCM) analysis of the cellular DNA synthetic cycle in limb buds. A dose-related accumulation of cells in the S and G2/M phases was observed at 4 and 8 hr after maternal dosing. S-phase accumulation was the most sensitive indicator of effect; a dose-related increase in the percentage of hindlimb bud cells in S-phase was evident at all dosages 4 hr after maternal dosing. By 28 hr postdosing, a normal cell cycle phase distribution was observed at doses of < 0.3 mg/kg. However, cell cycle perturbations persisted at higher dosages. NBS staining demonstrated inc...Continue Reading

References

Jul 10, 1992·Cell·A Bird
Jan 1, 1990·Journal of Toxicology and Environmental Health·M B RosenN Chernoff
Jan 1, 1985·Pharmacology & Therapeutics·R L Momparler
Mar 1, 1989·Environmental Health Perspectives·L A Michalowsky, P A Jones
Jan 1, 1989·Teratogenesis, Carcinogenesis, and Mutagenesis·N ChernoffK K Sulik
Feb 1, 1974·The Journal of Cell Biology·P N Dean, J H Jett
Dec 15, 1982·Journal of Molecular Biology·S M Taylor, P A Jones
Jul 1, 1984·Archives of Toxicology·W SchmahlH Kriegel
Oct 1, 1984·Molecular and Cellular Biology·E FlatauP A Jones
Jul 1, 1994·Toxicology and Applied Pharmacology·R M ZuckerJ M Rogers
Aug 1, 1962·Developmental Biology·J W SAUNDERS, M T GASSELING

❮ Previous
Next ❯

Citations

Sep 25, 1999·Teratogenesis, Carcinogenesis, and Mutagenesis·S BranchB M Francis
Apr 12, 2002·Teratology·Mitchell B Rosen, Neil Chernoff
Oct 1, 2011·Journal of Bone and Mineral Metabolism·Arkady TorchinskyEugene Kobyliansky
Feb 19, 2009·Zygote : the Biology of Gametes and Early Embryos·Jian-Ning YuHong-Lin Liu
Feb 9, 2000·Clinical Genetics·J E Polifka, J M Friedman
Jun 8, 2013·ILAR Journal·Ratnam S SeelanRobert M Greene
Apr 19, 2002·Toxicological Sciences : an Official Journal of the Society of Toxicology·Rebecca E Watson, Jay I Goodman
Nov 19, 2003·Current Opinion in Oncology·Jean-Pierre Issa
Jan 14, 1999·Genes & Development·C P Walsh, T H Bestor
Nov 24, 2012·Zygote : the Biology of Gametes and Early Embryos·Ying LiangShi-En Zhu
Mar 14, 2014·Archives of Toxicology·Eyal MorNoam Shomron
Apr 27, 2004·Birth Defects Research. Part A, Clinical and Molecular Teratology·Sigmund J DegitzE Sidney Hunter
Apr 1, 2003·Journal of Applied Toxicology : JAT·F Javier Cisneros, Stacy Branch
Mar 4, 2010·Analytical Biochemistry·Yu Ye, James T Stivers
Aug 7, 2019·Birth Defects Research·Ratnam S SeelanRobert M Greene
Sep 15, 2020·Birth Defects Research·Michael A GarlandChengji J Zhou

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.